Product

Company

Clareo Health | miRNAs in High Grade Serous Ovarian Cancer

NCT05146505·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Age

Any age

Sex

FEMALE

Healthy volunteers

Not accepted

age\>18
Histological diagnosis of epithelial ovarian cancer
Patients eligible for surgery
Patients followed in the clinical care pathway c / o oncological gynecology (surgery and follow up)
informed consent

Patients with HCV, HBV and HIV
Patients with other malignancies diagnosed less than 5 years prior to the diagnosis of ovarian malignancy
Ovarian metastases of primary neoplasms of other organs
Presence of ascites for non-neoplastic causes

The record

StatusUnknown

PhaseNo phase

Taking part150

StartedOct 2021

UpdatedDec 6, 2021

Conditions

Where1